GO:1990520 separase-securin complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990520 (separase-securin complex) is a cellular component consisting of the protease separase bound to its inhibitor securin, which prevents premature cohesin cleavage until securin is degraded by the anaphase-promoting complex (APC).
• The complex is conserved from yeast to humans and its three-dimensional structure has been resolved by cryo-electron microscopy and X-ray crystallography, revealing an inhibitory mechanism where securin blocks the separase active site.
• Separase is a large protease that cleaves the cohesin subunit Scc1 (also called Rad21 or Mcd1) to allow sister chromatid separation during anaphase.
• Securin acts as a dual regulator: it inhibits separase catalytic activity and also functions as a chaperone required for separase folding and stability.
• Deregulation of the separase-securin complex leads to chromosome mis-segregation, aneuploidy, and is implicated in cancer and developmental disorders.
• Research on this complex uses knockout, point-mutation, knock-in, and overexpression cell models, combined with CRISPR screening and structural biology, to dissect its roles in chromosome segregation and disease.
Description
The separase-securin complex (GO:1990520) is a conserved protein assembly that governs the final step of chromosome segregation during cell division. Separase is a cysteine protease that cleaves the cohesin ring subunit Scc1/Rad21, a cleavage event that is essential for sister chromatid separation in anaphase. Securin binds tightly to separase, forming an inhibitory complex that prevents premature cohesin cleavage until the anaphase-promoting complex (APC) ubiquitylates securin and targets it for degradation. This regulatory mechanism ensures that chromosome separation occurs only after all chromosomes are properly attached to the mitotic spindle. Because errors in chromosome segregation lead to aneuploidy, a hallmark of cancer and developmental disorders, the separase-securin complex has become a focal point for researchers studying cell cycle control, genome stability, and tumorigenesis. Structural studies have revealed how securin inhibits separase and how separase is activated upon securin destruction, providing a molecular framework for understanding this critical checkpoint. This article integrates authoritative QuickGO data and verified PubMed literature to provide a comprehensive overview of the separase-securin complex, covering its definition, structure, regulation, disease relevance, and experimental models for research.
separase-securin complex At A Glance
| GO ID | GO:1990520 |
|---|---|
| GO term | separase-securin complex |
| Ontology | cellular_component |
| Synonym | Cut1-2 complex |
| Major function | Inhibition of separase protease activity until securin degradation by APC, enabling timely cohesin cleavage and chromosome separation |
| Complex components | Separase (a large cysteine protease) and securin (a chaperone and inhibitor) |
| Conservation | Conserved from yeast to humans; yeast Cut1-Cut2, C. elegans SEP-1-IFP-1, human ESPL1-PTTG1 |
| Structural resolution | Cryo-EM and crystal structures reveal securin binding at the separase active site |
| Regulation | Securin degradation by APC/C ubiquitin ligase triggers separase activation |
What Is GO:1990520?
The separase-securin complex is a protein complex composed of separase, a protease that cleaves cohesin during chromosome separation, and securin, a protease inhibitor that binds to and inhibits separase. Chromosome separation is blocked until securin is degraded by the anaphase-promoting complex (APC), which triggers separase activation and cohesin cleavage.
Why Is separase-securin complex Important in Cell Biology?
The separase-securin complex is essential for faithful chromosome segregation, and its dysfunction leads to aneuploidy, a hallmark of cancer and developmental disorders. Understanding its structure and regulation provides insights into cell cycle control and offers potential targets for cancer therapy.
• Ensures accurate chromosome segregation by preventing premature cohesin cleavage.
• Securin acts as both an inhibitor and a chaperone for separase folding and stability.
• Deregulation causes aneuploidy, which is linked to tumorigenesis and cancer progression.
• Mutations in separase or securin are associated with developmental disorders and cancer predisposition.
• Structural insights inform drug design targeting separase in cancer.
• The complex is a model for studying protease regulation and cell cycle checkpoints.
• Research on this complex aids understanding of meiosis and mitosis.
• It is a target for CRISPR-based functional genomics to identify synthetic lethal interactions.
Structure and Composition of separase-securin complex
Separase: The Catalytic Protease
In simple terms: Separase is the enzyme that cuts the cohesin ring to let chromosomes separate.
Separase is a large, multi-domain cysteine protease that cleaves the cohesin subunit Scc1/Rad21. It contains an N-terminal domain, a central catalytic domain with a conserved cysteine-histidine dyad, and a C-terminal domain involved in regulation. Structural studies show that separase adopts a closed conformation when bound to securin, with the active site occluded.
Securin: Inhibitor and Chaperone
In simple terms: Securin holds separase in check and also helps it fold properly.
Securin binds to separase with high affinity, inhibiting its protease activity. Beyond inhibition, securin functions as a chaperone that promotes separase folding and stability. The crystal structure of the yeast separase-securin complex reveals that securin inserts its C-terminal segment into the separase active site, blocking substrate access.
Complex Assembly and Conformational Changes
In simple terms: The two proteins lock together in a shape that keeps separase inactive.
Assembly of the separase-securin complex involves extensive interfaces. Cryo-EM structures of the metazoan complex show that securin binding induces a closed conformation of separase, which is relieved upon securin degradation. The complex is dynamic, with securin acting as a pseudo-substrate that must be removed for separase activation.
Conservation Across Species
In simple terms: The same basic complex is found in yeast, worms, and humans.
The separase-securin complex is conserved from yeast (Cut1-Cut2) to C. elegans (SEP-1-IFP-1) and humans (ESPL1-PTTG1). Structural and biochemical studies across these organisms have revealed common principles of inhibition and activation.
Key Genes Involved in GO:1990520 separase-securin complex
The following genes and proteins are key components or regulators of the separase-securin complex and its associated pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ESPL1 (Separase) | Catalytic protease that cleaves cohesin | Target for cancer therapy; mutations cause aneuploidy |
| PTTG1 (Securin) | Inhibits separase; chaperone for separase folding | Overexpressed in many cancers; prognostic marker |
| RAD21 (Scc1) | Cohesin subunit cleaved by separase | Mutations linked to Cornelia de Lange syndrome |
| SMC1A | Cohesin subunit | Cohesinopathy disorders |
| SMC3 | Cohesin subunit | Cohesinopathy disorders |
| STAG1/STAG2 | Cohesin subunits | Mutations in cancer |
| CDC20 | Activator of APC/C | Regulates securin degradation |
| APC/C subunits (e.g., APC1, APC2) | Ubiquitin ligase that targets securin | Cell cycle regulation |
| CDK1 | Phosphorylates separase and securin | Controls timing of activation |
| PLK1 | Phosphorylates securin | Regulates APC/C-mediated degradation |
| BUB1 | Spindle checkpoint kinase | Monitors chromosome attachment |
| MAD2 | Spindle checkpoint protein | Inhibits APC/C until attachment |
| CUT1 (yeast separase) | Yeast homolog of separase | Model organism studies |
| CUT2 (yeast securin) | Yeast homolog of securin | Model organism studies |
| SEP-1 (C. elegans separase) | Worm homolog of separase | Developmental studies |
| IFP-1 (C. elegans securin) | Worm homolog of securin | Developmental studies |
| CCNB1 (Cyclin B1) | Regulatory subunit of CDK1 | Cell cycle control |
| WAPL | Cohesin release factor | Antagonizes cohesin |
How Is separase-securin complex Regulated?
The separase-securin complex is regulated by the ubiquitin-proteasome system. The anaphase-promoting complex/cyclosome (APC/C), activated by CDC20, ubiquitylates securin, leading to its degradation by the proteasome. This degradation liberates separase, which then cleaves cohesin. Phosphorylation of securin by CDK1 and PLK1 primes it for APC/C recognition. Additionally, separase activity is further controlled by phosphorylation and by binding to other proteins such as Cdk1 and Mps1.
separase-securin complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PTTG1 (Securin) | Pituitary adenoma, breast cancer | Knockout and overexpression in cancer cell lines |
| ESPL1 (Separase) | Aneuploidy, tumorigenesis | Point mutation of catalytic cysteine; knockout |
| RAD21 | Cornelia de Lange syndrome | Knock-in of patient mutations in cell lines |
| SMC1A | Cornelia de Lange syndrome | Knockout and rescue with wild-type or mutant |
| CDC20 | Cancer, mitotic arrest | Knockout and inducible overexpression |
Cancer and Aneuploidy
Deregulation of the separase-securin complex leads to chromosome mis-segregation and aneuploidy, a hallmark of cancer. Overexpression of securin (PTTG1) is observed in multiple cancers, including pituitary, breast, and colorectal cancers, and is associated with poor prognosis. Separase (ESPL1) is also overexpressed in some tumors, and its inhibition reduces tumor growth in preclinical models.
Developmental Disorders
Mutations in cohesin subunits (e.g., RAD21, SMC1A, SMC3) that are cleaved by separase cause Cornelia de Lange syndrome, a developmental disorder characterized by growth retardation and limb defects. While direct mutations in separase or securin are rare, their dysfunction can contribute to cohesinopathies.
Infertility and Meiotic Defects
Proper regulation of the separase-securin complex is essential for meiosis. Defects in securin degradation or separase activation can lead to premature or delayed chromosome separation, resulting in aneuploid gametes and infertility.
From separase-securin complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of separase loss on chromosome segregation? | ESPL1 knockout cell lines (e.g., HCT116, HeLa) |
| How does securin degradation trigger separase activation? | PTTG1 knockout with inducible securin expression |
| What is the role of separase catalytic activity in tumor growth? | Point mutation (C2029S) knock-in in cancer cells |
| How does securin overexpression contribute to cancer? | PTTG1 overexpression in mammary epithelial cells |
| What are the interacting partners of separase-securin complex? | Tagged knock-in (e.g., GFP-ESPL1) for proteomics |
| Can CRISPR screening identify synthetic lethal targets with separase inhibition? | Genome-wide CRISPR knockout library in separase-deficient cells |
How to Study the separase-securin complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cryo-EM | 3D structure of the complex at near-atomic resolution | Understanding inhibitory mechanism |
| X-ray crystallography | Atomic structure of protein-protein interface | Mapping securin binding site |
| In vitro cleavage assay | Protease activity of separase | Testing inhibitors and mutants |
| Live-cell imaging | Dynamics of complex during mitosis | Chromosome segregation timing |
| Co-immunoprecipitation | Protein-protein interactions | Identifying complex components |
| CRISPR knockout screening | Gene essentiality and synthetic lethality | Finding new targets in cancer |
| Proteomics (AP-MS) | Interactome of separase-securin | Discovering novel regulators |
Structural Biology (Cryo-EM and X-ray Crystallography)
Cryo-electron microscopy and X-ray crystallography have been used to determine the structures of the separase-securin complex from yeast, C. elegans, and humans, revealing the molecular basis of inhibition and activation.
Biochemical Assays for Protease Activity
In vitro cleavage assays using recombinant separase and securin, along with cohesin substrates, measure protease activity and inhibition. These assays are complemented by mutagenesis to identify key residues.
Cell Cycle Synchronization and Live-Cell Imaging
Synchronization of cells in mitosis followed by live-cell imaging of fluorescently tagged separase, securin, and cohesin allows real-time visualization of complex dynamics and chromosome segregation.
CRISPR-Based Functional Genomics
Genome-wide CRISPR knockout screens can identify genes that are synthetic lethal with separase or securin mutations, uncovering pathways that compensate for complex dysfunction.
How CRISPR Can Be Used to Study GO:1990520 separase-securin complex
Knockout
CRISPR knockout of ESPL1 or PTTG1 in cell lines abolishes complex function, leading to premature cohesin cleavage or mitotic arrest. These models are used to study the consequences of complex loss on chromosome segregation and cell viability.
Point Mutation
Point mutations in the catalytic cysteine of separase (e.g., C2029S) or in securin's degradation motif can be introduced via CRISPR to dissect the specific contributions of protease activity versus protein-protein interactions.
Knock-in
Knock-in of tagged versions of separase or securin (e.g., GFP, HA) allows for live-cell imaging and proteomic analysis of the complex in its native context. Knock-in of patient-derived mutations can model disease-associated variants.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of PTTG1 or ESPL1 can mimic the overexpression observed in cancers, enabling studies on tumorigenesis and aneuploidy.
How EDITGENE Supports separase-securin complex Research
Researchers studying separase-securin complex-related genes often need to determine whether a candidate gene is causally involved in chromosome segregation, aneuploidy, or cancer. EDITGENE provides a comprehensive suite of CRISPR services to enable precise genetic manipulation and functional interrogation of this complex.
Contact EDITGENE today to design your custom CRISPR model for separase-securin complex research.
Frequently Asked Questions About separase-securin complex
What is the separase-securin complex?
The separase-securin complex (GO:1990520) is a protein complex of separase, a protease that cleaves cohesin, and securin, its inhibitor. It prevents premature chromosome separation until securin is degraded by the APC.
What genes are involved in the separase-securin complex?
Key genes include ESPL1 (separase), PTTG1 (securin), and cohesin subunits like RAD21, SMC1A, and SMC3. Regulatory genes include CDC20, CDK1, and PLK1.
What is the function of securin in the separase-securin complex?
Securin inhibits separase protease activity and also acts as a chaperone for separase folding. Its degradation by APC/C triggers separase activation.
How is the separase-securin complex regulated?
It is regulated by APC/C-mediated ubiquitylation and degradation of securin, which is primed by phosphorylation by CDK1 and PLK1.
What diseases are associated with the separase-securin complex?
Deregulation is linked to cancer (aneuploidy, tumorigenesis), developmental disorders (cohesinopathies), and infertility.
What is the structure of the separase-securin complex?
Structures solved by cryo-EM and crystallography show securin binding to the separase active site, locking it in an inactive conformation.
How can CRISPR be used to study the separase-securin complex?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of the complex in chromosome segregation and disease.
What model organisms are used to study the separase-securin complex?
Yeast (Cut1-Cut2), C. elegans (SEP-1-IFP-1), and human cell lines are commonly used.
What are the research methods for studying the separase-securin complex?
Methods include cryo-EM, X-ray crystallography, in vitro cleavage assays, live-cell imaging, and CRISPR screens.
Why is the separase-securin complex important for cancer research?
Because its dysfunction causes aneuploidy, a hallmark of cancer, and securin overexpression is observed in many tumors, making it a potential therapeutic target.
Conclusion
The separase-securin complex (GO:1990520) is a critical regulator of chromosome segregation, ensuring that cohesin cleavage occurs only after all chromosomes are properly attached to the spindle. Its structure, regulation, and disease relevance have been extensively studied, providing a paradigm for protease control and cell cycle checkpoints. Continued research using advanced CRISPR models and structural techniques will further illuminate its roles in health and disease.
References
- 1. Luo S et al.. 2021. Structure and Function of the Separase-Securin Complex.. Subcell Biochem 96:217-232 PMID: 33252730
- 2. Luo S et al.. 2018. Structural biology of the separase-securin complex with crucial roles in chromosome segregation.. Curr Opin Struct Biol 49:114-122 PMID: 29452922
- 3. Boland A et al.. 2017. Cryo-EM structure of a metazoan separase-securin complex at near-atomic resolution.. Nat Struct Mol Biol 24(4):414-418 PMID: 28263324
- 4. Singleton MR et al.. 2017. Separase-securin complex: a cunning way to control chromosome segregation.. Nat Struct Mol Biol 24(4):337-339 PMID: 28384135
- 5. Bachmann G et al.. 2016. A closed conformation of the Caenorhabditis elegans separase-securin complex.. Open Biol 6(4):160032 PMID: 27249343
- 6. Luo S et al.. 2017. Molecular mechanism for the regulation of yeast separase by securin.. Nature 542(7640):255-259 PMID: 28146474
- 7. Hornig NC et al.. 2002. The dual mechanism of separase regulation by securin.. Curr Biol 12(12):973-82 PMID: 12123570
- 8. Viadiu H et al.. 2005. Domain structure of separase and its binding to securin as determined by EM.. Nat Struct Mol Biol 12(6):552-3 PMID: 15880121
